SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-18-000157
Filing Date
2018-03-06
Accepted
2018-03-06 16:11:37
Documents
5
Period of Report
2018-04-15
Effectiveness Date
2018-03-06

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv486986-def14a.htm DEF 14A 591965
2 GRAPHIC lg_protalix.jpg GRAPHIC 25457
3 GRAPHIC sig_yossi-maimon.jpg GRAPHIC 9221
4 GRAPHIC tv486986_pc1.jpg GRAPHIC 376554
5 GRAPHIC tv486986_pc2.jpg GRAPHIC 115772
  Complete submission text file 0001571049-18-000157.txt   1304354
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 18669994
SIC: 2836 Biological Products, (No Diagnostic Substances)